Literature DB >> 7325962

Isolation and analysis of human parathyrin in parathyroid tissue and plasma. Use of reversed-phase liquid chromatography.

H P Bennett, S Solomon, D Goltzman.   

Abstract

Reversed-phase liquid chromatography techniques have been used to extract and purify human parathyrin from parathyroid adenomas and to analyse the circulating forms of human parathyrin in plasma. Both the supernatant from tissue homogenates, and plasma were extracted with octadecylsilyl-silica (ODS-silica) in a batch procedure. Extracts were subjected to reversed-phase high-pressure liquid chromatography (h.p.l.c.) employing solvent systems composed of aqueous acetonitrile containing trifluoroacetic acid or heptafluorobutyric acid as hydrophobic ion-pairing reagents. The volatile solvents facilitated the radioimmunoassay, bioassay in vitro and amino acid analysis of column fractions and permitted monitoring for u.v. absorbance at 210nm. Isolated glandular parathyrin was found to be homogeneous by sodium dodecyl sulphate/urea/polyacrylamide-gel electrophoresis, to have an amino acid composition conforming to that of human parathyrin-(1--84)-tetraoctacontapeptide and to be bioactive in both renal adenylate cyclase and cytochemical bioassays. ODS-silica extraction permitted examination of large plasms samples by reversed-phase h.p.l.c., facilitating the resolution of the various circulating molecular forms of parathyrin according to their hydrophobic character. Because of its rapidity, excellent recovery and high resolving power, the methodology utilized is uniquely suited to the purification and analysis of parathyrin in tissues and body fluids.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325962      PMCID: PMC1163138          DOI: 10.1042/bj1970391

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Metabolism and biological activity of parathyroid hormone in renal cortical membranes.

Authors:  D Goltzman; A Peytremann; E N Callahan; G V Segre; J T Potts
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

2.  Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues.

Authors:  D Goltzman; D Goltzmann; A Peytremann; E Callahan; G W Tregear; J T Potts
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

3.  Use of octadecasilyl-silica for the extraction and purification of peptides in biological samples. Application to the identification of circulating metabolites of corticotropin-(1-24)-tetracosapeptide and somatostatin in vivo.

Authors:  H P Bennett; A M Hudson; C McMartin; G E Purdon
Journal:  Biochem J       Date:  1977-10-15       Impact factor: 3.857

4.  A chick bioassay for parathyroid hormone.

Authors:  J A Parsons; B Reit; C J Robinson
Journal:  Endocrinology       Date:  1973-02       Impact factor: 4.736

5.  Isolation of human parathyroid hormone.

Authors:  H T Keutmann; P M Barling; G N Hendy; G V Segre; H D Niall; G D Aurbach; J T Potts; J L O'Riordan
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

6.  Purification of human parathyroid hormone: recent studies and further observations.

Authors:  H T Keutmann; G N Hendy; M Boehnert; J L O'Riordan; J T Potts
Journal:  J Endocrinol       Date:  1978-07       Impact factor: 4.286

7.  Complete amino acid sequence of human parathyroid hormone.

Authors:  H T Keutmann; M M Sauer; G N Hendy; L H O'Riordan; J T Potts
Journal:  Biochemistry       Date:  1978-12-26       Impact factor: 3.162

8.  Parathyroid autotransplantation in primary parathyroid hyperplasia.

Authors:  S A Wells; G J Ellis; J C Gunnells; A B Schneider; L M Sherwood
Journal:  N Engl J Med       Date:  1976-07-08       Impact factor: 91.245

9.  Conversion of proparathyroid hormone to parathyroid hormone: studies in vitro with trypsin.

Authors:  D Goltzman; E N Callahan; G W Tregear; J T Potts
Journal:  Biochemistry       Date:  1976-11-16       Impact factor: 3.162

10.  International collaborative study of N.I.B.S.C. research standard for human parathyroid hormone for immunoassay.

Authors:  J M Zanelli; R E Gaines Das
Journal:  J Endocrinol       Date:  1980-08       Impact factor: 4.286

View more
  4 in total

1.  Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype.

Authors:  M Koutsilieris; S A Rabbani; H P Bennett; D Goltzman
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters.

Authors:  M S Calvo; M J Fryer; K J Laakso; R A Nissenson; P A Price; T M Murray; H Heath
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

3.  Effects of dietary-induced hyperparathyroidism on the parathyroid hormone-receptor-adenylate cyclase system of canine kidney. Evidence for postreceptor mechanism of desensitization.

Authors:  J Tamayo; E Bellorin-Font; K J Martin
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

Review 4.  Renal adaptation to phosphate deprivation: lessons from the X-linked Hyp mouse.

Authors:  H S Tenenhouse; J Martel
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.